Target intelligence / Profile preview

TOMM22 pseudogene 2 (TOMM22P2)

Target
TOMM22P2
Molecular classification
Other (Pseudogene; does not encode a functional protein)
01

Overview

TOMM22P2 (TOMM22 pseudogene 2) is a pseudogene located on chromosome Y (chrY:2827982-2828218, human genome build hg38), annotated in GenBank and Ensembl as a non-coding, non-functional sequence with sequence similarity to the protein-coding TOMM22 gene, but does not encode a functional mitochondrial protein[5][7]. Pseudogenes do not produce functional proteins and typically lack regulatory or disease relevance; TOMM22P2 is not considered a receptor, enzyme, transporter, nor a therapeutic target. It is distinct from the functional TOMM22 gene (translocase of outer mitochondrial membrane 22 homolog), which is central to mitochondrial protein import, but TOMM22P2 itself is simply a genomic remnant without biological activity or clinical significance[5][7]. TOMM22P2 should not be confused with the functional mitochondrial import receptor subunit TOM22, officially known as TOMM22, which *is* a validated therapeutic target and biomarker in multiple diseases including cancer[1][2][3][11]. TOMM22P2 is annotated in major genomic databases (NCBI Gene: 100499417; Ensembl: ENSG00000232195) as a pseudogene, though these entries contain no evidence for protein expression or function[5][7]. If you require information on TOMM22 (the functional protein-coding gene and receptor), please clarify, as its molecular and therapeutic relevance is entirely distinct from TOMM22P2.

Other names
TOMM22P2Translocase of outer mitochondrial membrane 22 homolog pseudogene 2

Beyond the preview

Go deeper on TOMM22 pseudogene 2 (TOMM22P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TOMM22 pseudogene 2 (TOMM22P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call